logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Impact of therapeutic research on informed consent and the ethics of clinical trials : A medical oncology perspective.

    Article - En anglais

    Purpose 

    To create a more meaningful understanding of the informed consent process as it has come to be practiced and regulated in clinical trials, this discussion uses the experience gained from the conduct of therapeutic research that involves cancer patients.

    Design 

    After an introduction of the ethical tenets of the consent process in clinical research that involves potentially vulnerable patients as research subjects, background that details the use of written consent documents and of the term « informed consent » is provided.

    Studies from the cancer setting that examine the inadequacies of written consent documents, and the outcome of the consent process itself, are reviewed.

    Two ethically challenging areas of cancer clinical research, the phase I trial and the randomized controlled trial, are discussed briefly as a means of highlighting many dilemmas present in clinical trials.

    Before concluding, areas for future research are discussed.

    Results 

    Through an exclusive cancer research perspective, many current deficiencies in the informed consent process for therapeutic clinical trials can be critically examined.

    Also, new directions for improvements and areas of further research can be outlined and discussed objectively.

    The goals of such improvements and research should be prevention of further misguided or ineffective efforts to regulate the informed consent process. (...)

    Mots-clés Pascal : Tumeur maligne, Anticancéreux, Essai clinique, Consentement éclairé, Ethique, Chimiothérapie, Traitement, Recherche fondamentale, Homme

    Mots-clés Pascal anglais : Malignant tumor, Antineoplastic agent, Clinical trial, Informed consent, Ethics, Chemotherapy, Treatment, Fundamental research, Human

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0268269

    Code Inist : 002B30A09. Création : 16/11/1999.